Should Covaxin trial continue till 130 cases are recorded?

Considering that recruitment and complete vaccination of all trial participants has been achieved, the drug regulator has to take a decision on the number of cases required for licensing — currently available cases (which is likely to be more than 43), second endpoint of 87 cases or 130 cases as originally planned, for which the … Continue reading Should Covaxin trial continue till 130 cases are recorded?

Advertisement

Why Russia’s rushed-up coronavirus vaccine is mired in ethical, safety landmine

Russia registering a vaccine for novel coronavirus even before beginning a Phase-3 trial and promising to  begin full-scale production of the vaccine in September to make it available by November is riddled with safety and ethical issues. But virologist Dr Jacob John feels a vaccine using a recombinant adenovirus construct to ferry the synthetic genetic … Continue reading Why Russia’s rushed-up coronavirus vaccine is mired in ethical, safety landmine